US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Indaptus Therapeutics, Inc.

0.3391

-0.0058-1.68%

Volume:231.70K

Turnover:77.70K

Market Cap:5.44M

PE:-0.23

High:0.3496

Open:0.3220

Low:0.3201

Close:0.3449

Loading ...

Overview Company News Filings

Indaptus Therapeutics Inc. Conducted Annual Meeting

Indaptus Therapeutics Doses First Patient in Phase 1B/2 Combination Study of Decoy20 With Pd-1 Checkpoint Inhibitor Tislelizumab

THOMSON REUTERS

Indaptus Therapeutics Reports Q1 2025 Loss Per Share of $0.32, Improved from $0.45 in Q1 2024; R&D Expenses Rise to $2.8M

Indaptus Therapeutics Says New Data on Decoy20 Shows Broad Immune System Activation in Cancer Patients

MT Newswires Live

Indaptus Therapeutics Reports New Data Demonstrating Successful Broad Immune System Activation in Weekly Dosing Trial of Decoy20

THOMSON REUTERS

Indaptus Therapeutics Initiates Phase 1 Combination Study of Decoy20 with PD-1 Checkpoint Inhibitor Tislelizumab

EXCLUSIVE: Indaptus Therapeutics Starts Phase 1 Combination Study of Decoy20 With BeiGene's Cancer Drug For Advanced Solid Tumors

Indaptus Therapeutics FY24 EPS $(1.61) Up From $($1.83) YoY

BRIEF-Indaptus Therapeutics reports full-year loss of $1.61 per share

Indaptus Therapeutics FY EPS USD -1.61

THOMSON REUTERS

Press Release: Indaptus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update

BRIEF-Indaptus Therapeutics Expands Patent Portfolio In China, Japan, And Israel, Strengthening Its Intellectual Property For Infectious Disease And Cancer Treatments

Indaptus Therapeutics expands patent portfolio in China, Japan, Israel

Indaptus Therapeutics Expands Patent Portfolio in China, Japan, and Israel, Strengthening Its Intellectual Property for Infectious Disease and Cancer Treatments

THOMSON REUTERS

Indaptus Therapeutics Expands Patent Portfolio in China, Japan, and Israel, Strengthening its Intellectual Property for Infectious Disease and Cancer Treatments

Indaptus Therapeutics Enters Standby Equity Purchase Deal With YA II PN

MT Newswires Live

BRIEF-Indaptus Therapeutics Enters Equity Purchase Agreement With Ya II Pn

Indaptus Therapeutics Inc - Can Sell up to $20 Million of Stock to Yorkville

THOMSON REUTERS

Indaptus Therapeutics Inc - Enters Equity Purchase Agreement With Ya Ii Pn

THOMSON REUTERS

BRIEF-Indaptus Therapeutics Files Prospectus Relating To Proposed Resale By Selling Stockholders Of Up To 4.4 Million Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/INDP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INDP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INDP\",,,,,undefined,":{"symbol":"INDP","market":"US","secType":"STK","nameCN":"Indaptus Therapeutics, Inc.","latestPrice":0.3391,"timestamp":1749758400000,"preClose":0.3449,"halted":0,"volume":231704,"delay":0,"floatShares":9783100,"shares":16034444,"eps":-1.462092,"marketStatus":"Pre-Mkt","change":-0.0058,"latestTime":"06-13 06:22:55 EDT","open":0.322,"high":0.3496,"low":0.3201,"amount":77700.7547096,"amplitude":0.085532,"askPrice":0.3391,"askSize":100,"bidPrice":0.2927,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.462092,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1749821400000},"marketStatusCode":1,"adr":0,"listingDate":1438660800000,"exchange":"NASDAQ","adjPreClose":0.3391,"postHourTrading":{"tag":"盘后","latestPrice":0.3391,"preClose":0.3391,"latestTime":"19:28 EDT","volume":47,"amount":15.3243,"timestamp":1749770936971},"volumeRatio":0.24149653975031188},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INDP\",,,,,undefined,":{"symbol":"INDP","floatShares":9783100,"roa":"-122.21%","roe":"-259.00%","lyrEps":-1.605653,"volumeRatio":0.24149653975031188,"shares":16034444,"dividePrice":0,"high":0.3496,"amplitude":0.085532,"preClose":0.3449,"low":0.3201,"week52Low":0.31,"pbRate":"1.94","week52High":2.7,"institutionHeld":0,"latestPrice":0.3391,"eps":-1.462092,"divideRate":0,"volume":231704,"delay":0,"ttmEps":-1.462092,"open":0.322,"prevYearClose":0.8421,"prevWeekClose":0.3433,"prevMonthClose":0.338,"prevQuarterClose":0.5499,"fiveDayClose":0.3469,"twentyDayClose":0.4236,"sixtyDayClose":0.81},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INDP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2542532276","title":"Indaptus Therapeutics Inc. Conducted Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2542532276","media":"Reuters","labels":["shareholding","conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542532276?lang=en_us&edition=fundamental","pubTime":"2025-06-12 04:01","pubTimestamp":1749672119,"startTime":"0","endTime":"0","summary":"Indaptus Therapeutics Inc. held its Annual Meeting on June 10, 2025. The election of Mark J. Gilbert, Hila Karah, and Robert E. Martell as Class I directors was approved. The ratification of Haskell & White LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was approved. An amendment to the company's Amended and Restated Certificate of Incorporation to effect a reverse stock split within a specified range was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Indaptus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commissio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250611:nNDL27zX21:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDP","BK4139"],"gpt_icon":0},{"id":"2540760499","title":"Indaptus Therapeutics Doses First Patient in Phase 1B/2 Combination Study of Decoy20 With Pd-1 Checkpoint Inhibitor Tislelizumab","url":"https://stock-news.laohu8.com/highlight/detail?id=2540760499","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540760499?lang=en_us&edition=fundamental","pubTime":"2025-06-02 20:00","pubTimestamp":1748865602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nTUA3SKTVY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INDP","BK4139"],"gpt_icon":0},{"id":"2535252620","title":"Indaptus Therapeutics Reports Q1 2025 Loss Per Share of $0.32, Improved from $0.45 in Q1 2024; R&D Expenses Rise to $2.8M","url":"https://stock-news.laohu8.com/highlight/detail?id=2535252620","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535252620?lang=en_us&edition=fundamental","pubTime":"2025-05-14 20:01","pubTimestamp":1747224105,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Indaptus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nNDL2XCrnZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INDP"],"gpt_icon":0},{"id":"2520456045","title":"Indaptus Therapeutics Says New Data on Decoy20 Shows Broad Immune System Activation in Cancer Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2520456045","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520456045?lang=en_us&edition=fundamental","pubTime":"2025-03-20 20:47","pubTimestamp":1742474861,"startTime":"0","endTime":"0","summary":"Indaptus Therapeutics  reported Thursday new data from an ongoing phase 1 trial of Decoy20, which validated Decoy20's ability to modulate a patient's immune system in a \"controlled and potentially meaningful way.\"The biotechnology company said weekly treatment with Decoy20 led to broad immune cell trafficking that is a key pharmacodynamic marker, which is \"critical for successful anti-tumor therapy,\" Indaptus Chief Scientific Officer Michael Newman said.INDP shares were 3% lower in recent premarket activity.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LENZ","INDP"],"gpt_icon":0},{"id":"2520114453","title":"Indaptus Therapeutics Reports New Data Demonstrating Successful Broad Immune System Activation in Weekly Dosing Trial of Decoy20","url":"https://stock-news.laohu8.com/highlight/detail?id=2520114453","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520114453?lang=en_us&edition=fundamental","pubTime":"2025-03-20 20:00","pubTimestamp":1742472001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250320:nTUA9SPTXB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INDP"],"gpt_icon":0},{"id":"2520678244","title":"Indaptus Therapeutics Initiates Phase 1 Combination Study of Decoy20 with PD-1 Checkpoint Inhibitor Tislelizumab","url":"https://stock-news.laohu8.com/highlight/detail?id=2520678244","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520678244?lang=en_us&edition=fundamental","pubTime":"2025-03-18 20:00","pubTimestamp":1742299200,"startTime":"0","endTime":"0","summary":"New trial arm to evaluate safety, dosing and preliminary anti-tumor activity in advanced solid tumors. NEW YORK, March 18, 2025  -- Indaptus Therapeutics, Inc. , a clinical-stage biotechnology company dedicated to developing novel treatments for cancer and viral infections, today announced that it has advanced toa new expansion arm of its Phase 1b/2 clinical trial of Decoy20. This expansion will evaluate the combination of Decoy20 with BeiGene’s PD-1 checkpoint inhibitor, tislelizumab, with a focus on safety, dose optimization, and early signs of anti-tumor activity.Jeffrey Meckler, CEO of Indaptus, commented, “This marks a pivotal step forward for Indaptus and our Decoy platform. Preclinical research has consistently shown that Decoy20 works synergistically with a checkpoint inhibitor, and we now have the opportunity to test that in patients for the first time. While this initial phase will focus on safety and tolerability, we are laying the groundwork for what could be a game-changin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/indaptus-therapeutics-initiates-phase-1-120000013.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PD","BK4139","LU1169589451.USD","INDP","BK4023","LU1169590202.USD","LENZ","NLR","BK4606"],"gpt_icon":1},{"id":"2520077627","title":"EXCLUSIVE: Indaptus Therapeutics Starts Phase 1 Combination Study of Decoy20 With BeiGene's Cancer Drug For Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2520077627","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520077627?lang=en_us&edition=fundamental","pubTime":"2025-03-18 19:45","pubTimestamp":1742298344,"startTime":"0","endTime":"0","summary":"On Tuesday, Indaptus Therapeutics, Inc.  announced it advanced toa new expansion arm of its Phase 1b/2 clinical trial of Decoy20.The expansion will evaluate the combination of Decoy20 with BeiGene Ltd's  PD-1 checkpoint inhibitor, tislelizumab, focusing on safety, dose optimization, and early signs of anti-tumor activity.Initial participants will first receive one week of Decoy20 monotherapy intravenously before starting the combination treatment with Decoy20 + tislelizumab.The first few patients in the combination phase will be enrolled sequentially to monitor safety.After review by the trial's Safety Review Committee, unrestricted enrollment will begin.Participants will receive both treatments for up to one year or until disease progression, unacceptable toxicity, or withdrawal from the study.Jeffrey Meckler, CEO of Indaptus, commented, \"This marks a pivotal step forward for Indaptus and our Decoy platform. Preclinical research has consistently shown that Decoy20 works synergisticall","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exclusive-indaptus-therapeutics-starts-phase-114544005.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0031619046.USD","IE00B7SZL793.SGD","BK4157","AEIS","BK4139","IE00B66KJ199.SGD","LENZ","IE00B19Z4B17.USD","ONC","INDP"],"gpt_icon":0},{"id":"2519833980","title":"Indaptus Therapeutics FY24 EPS $(1.61) Up From $($1.83) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2519833980","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519833980?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:49","pubTimestamp":1741866583,"startTime":"0","endTime":"0","summary":"Indaptus Therapeutics FY24 EPS $(1.61) Up From $($1.83) YoY","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44299263/indaptus-therapeutics-fy24-eps-1-61-up-from-1-83-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","INDP"],"gpt_icon":0},{"id":"2519838784","title":"BRIEF-Indaptus Therapeutics reports full-year loss of $1.61 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2519838784","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519838784?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:40","pubTimestamp":1741866004,"startTime":"0","endTime":"0","summary":"BRIEF-Indaptus Therapeutics reports full-year loss of $1.61 per shareMarch 13 (Reuters) - Indaptus Therapeutics Inc INDP.O:INDAPTUS THERAPEUTICS FY EPS USD -1.61Source text: ID:nGNXb6WL8NFurther company coverage: INDP.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nPLXAE4351:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INDP"],"gpt_icon":0},{"id":"2519838338","title":"Indaptus Therapeutics FY EPS USD -1.61","url":"https://stock-news.laohu8.com/highlight/detail?id=2519838338","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519838338?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:30","pubTimestamp":1741865401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250313:nPLXAE4351:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INDP"],"gpt_icon":0},{"id":"2519386248","title":"Press Release: Indaptus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2519386248","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519386248?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:30","pubTimestamp":1741865400,"startTime":"0","endTime":"0","summary":"Indaptus Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update. -- Company Achieves Key Clinical Milestone with more than 20 Patients. Enrolled in Weekly Dosing Cohort of Phase 1 Trial of Decoy20. -- Pharmacodynamic immune activation biomarker and pharmacokinetics profiles. in initial data sets appear to meet or exceed initial expectations. -- Early signs of potential benefit emerge with some patients demonstrating. Jeffrey Meckler, Chief Executive Officer of Indaptus, commented, \"We continue to make significant progress in our Phase 1 trial of Decoy20, and enrolling more than 20 patients in the weekly dosing cohort marks an important milestone. We are particularly encouraged by the emerging clinical data, with some patients in this cohort demonstrating stable disease - an early sign that Decoy20's immune-modulating approach may be having a meaningful impact. With a favorable safety profile observed so far, we are focused on efficiently a","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4606","BK4080","LENZ","BK4231","SITC","BK4139","INDP","NLR"],"gpt_icon":0},{"id":"2516967674","title":"BRIEF-Indaptus Therapeutics Expands Patent Portfolio In China, Japan, And Israel, Strengthening Its Intellectual Property For Infectious Disease And Cancer Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2516967674","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516967674?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:25","pubTimestamp":1741094714,"startTime":"0","endTime":"0","summary":"BRIEF-Indaptus Therapeutics Expands Patent Portfolio In China, Japan, And Israel, Strengthening Its Intellectual Property For Infectious Disease And Cancer TreatmentsMarch 4 (Reuters) - Indaptus Thera","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nFWN3PN0FZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INDP"],"gpt_icon":0},{"id":"2516335679","title":"Indaptus Therapeutics expands patent portfolio in China, Japan, Israel","url":"https://stock-news.laohu8.com/highlight/detail?id=2516335679","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516335679?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:16","pubTimestamp":1741094196,"startTime":"0","endTime":"0","summary":"Indaptus Therapeutics (INDP) has secured new patent approvals in China, Japan and Israel for its Decoy platform. These patents cover the use of Dec...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/indaptus-therapeutics-expands-patent-portfolio-in-china-japan-israel?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/indaptus-therapeutics-expands-patent-portfolio-in-china-japan-israel?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","INDP"],"gpt_icon":0},{"id":"2516431675","title":"Indaptus Therapeutics Expands Patent Portfolio in China, Japan, and Israel, Strengthening Its Intellectual Property for Infectious Disease and Cancer Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2516431675","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516431675?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:01","pubTimestamp":1741093270,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nFWN3PN0FZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INDP"],"gpt_icon":0},{"id":"2516675441","title":"Indaptus Therapeutics Expands Patent Portfolio in China, Japan, and Israel, Strengthening its Intellectual Property for Infectious Disease and Cancer Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2516675441","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516675441?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:00","pubTimestamp":1741093200,"startTime":"0","endTime":"0","summary":"NEW YORK, March 04, 2025  -- Indaptus Therapeutics, Inc. , a clinical-stage biotechnology company dedicated to developing novel treatments for cancer and viral infections, announced today that it has secured new patent approvals in China, Japan and Israel for its Decoy platform. These patents cover the use of Decoy bacteria compositions for preventing or treating Hepatitis B virus  and human immunodeficiency virus  – two diseases that continue to pose major global health challenges. The patents also extend to combination therapies with a variety of both approved and investigational treatments.Dr. Michael Newman, Founder and Chief Scientific Officer of Indaptus, commented, “The allowance of these patents in key international markets highlights the potential of our Decoy platform in the fight against chronic infectious diseases. With millions of people affected by HBV and HIV worldwide, expanding our intellectual property reinforces the novelty and therapeutic promise of our approach.”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/indaptus-therapeutics-expands-patent-portfolio-130000815.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["INDP","NLR","BK4139","BK4606","LENZ"],"gpt_icon":0},{"id":"2511406300","title":"Indaptus Therapeutics Enters Standby Equity Purchase Deal With YA II PN","url":"https://stock-news.laohu8.com/highlight/detail?id=2511406300","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511406300?lang=en_us&edition=fundamental","pubTime":"2025-02-13 01:29","pubTimestamp":1739381378,"startTime":"0","endTime":"0","summary":"Indaptus Therapeutics  said Wednesday it has entered a standby equity purchase agreement with YA II PN, or Yorkville.Under the deal, the company can sell up to $20 million worth of its common stock to Yorkville over the next 36 months but is not obligated to do so. The company also issued 305,960 common shares to Yorkville as a commitment for Yorkville to purchase these shares, according to a filing.Indaptus said it cannot sell more than about 2.8 million shares without shareholder approval or unless the average price per share is at least $0.82. Additionally, Yorkville can't own more than 9.99% of the company's voting shares.Before any shares can be sold, the company is required to file a registration statement with the US Securities and Exchange Commission for the shares involved in this agreement.The agreement replaces the previous purchase agreement the company had with Lincoln Park Capital Fund, which was terminated on Wednesday, it said.Shares of Indaptus Therapeutics fell past 2","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LENZ","BK4215","BK4588","INDP","EQR","BK4585","PN"],"gpt_icon":0},{"id":"2510706613","title":"BRIEF-Indaptus Therapeutics Enters Equity Purchase Agreement With Ya II Pn","url":"https://stock-news.laohu8.com/highlight/detail?id=2510706613","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510706613?lang=en_us&edition=fundamental","pubTime":"2025-02-12 22:29","pubTimestamp":1739370563,"startTime":"0","endTime":"0","summary":"BRIEF-Indaptus Therapeutics Enters Equity Purchase Agreement With Ya II PnFeb 12  - Indaptus Therapeutics INDP.O:INDAPTUS THERAPEUTICS INC - ENTERS EQUITY PURCHASE AGREEMENT WITH YA II PNINDAPTUS THERAPEUTICS INC - CAN SELL UP TO $20 MILLION OF STOCK TO YORKVILLESource text: [ID:n0001493152-25-006052]Further company coverage: INDP.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nFWN3P31RX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDP","BK4139"],"gpt_icon":0},{"id":"2510721377","title":"Indaptus Therapeutics Inc - Can Sell up to $20 Million of Stock to Yorkville","url":"https://stock-news.laohu8.com/highlight/detail?id=2510721377","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510721377?lang=en_us&edition=fundamental","pubTime":"2025-02-12 22:23","pubTimestamp":1739370205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nFWN3P31RX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INDP"],"gpt_icon":0},{"id":"2510377723","title":"Indaptus Therapeutics Inc - Enters Equity Purchase Agreement With Ya Ii Pn","url":"https://stock-news.laohu8.com/highlight/detail?id=2510377723","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510377723?lang=en_us&edition=fundamental","pubTime":"2025-02-12 22:23","pubTimestamp":1739370205,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250212:nFWN3P31RX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INDP","BK4139"],"gpt_icon":0},{"id":"2509251966","title":"BRIEF-Indaptus Therapeutics Files Prospectus Relating To Proposed Resale By Selling Stockholders Of Up To 4.4 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2509251966","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509251966?lang=en_us&edition=fundamental","pubTime":"2025-02-06 05:24","pubTimestamp":1738790677,"startTime":"0","endTime":"0","summary":"BRIEF-Indaptus Therapeutics Files Prospectus Relating To Proposed Resale By Selling Stockholders Of Up To 4.4 Million SharesFeb 5  - Indaptus Therapeutics Inc INDP.O:INDAPTUS THERAPEUTICS INC: FILES PROSPECTUS RELATING TO PROPOSED RESALE BY SELLING STOCKHOLDERS OF UP TO 4.4 MILLION SHARESSource text: [ID:n0001493152-25-005016]Further company coverage: INDP.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250205:nFWN3OW1AY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDP","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":34,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INDP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-14","symbol":"INDP","fiscalQuarterEnding":"2025/03","expectedEps":-0.41,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2025-03-13","symbol":"INDP","fiscalQuarterEnding":"2024/12","expectedEps":-0.41,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741838400000,"reportTimeType":"pre","actualEps":-0.38},{"market":"US","date":"2024-11-12","symbol":"INDP","fiscalQuarterEnding":"2024/09","expectedEps":-0.47,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2024-08-12","symbol":"INDP","fiscalQuarterEnding":"2024/06","expectedEps":-0.54,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723435200000,"reportTimeType":"pre","actualEps":-0.47},{"market":"US","date":"2024-05-08","symbol":"INDP","fiscalQuarterEnding":"2024/03","expectedEps":-0.57,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INDP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INDP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1671076800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INDP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INDP","date":"2025-06-12","current":-0.351178,"percent":0.991525,"low":-18.4548,"twenty":-3.157194,"median":-1.168157,"eighty":-0.927577,"high":-0.323992,"avg":-2.864217,"sd":3.909687,"marketCap":5530279},"quantilePoints":[{"date":"2021-08-06","current":-14.339657,"twenty":-15.057136,"median":-14.339657,"eighty":-13.763017,"marketCap":52167542},{"date":"2021-08-13","current":-12.289012,"twenty":-14.509058,"median":-13.737837,"eighty":-13.304373,"marketCap":44707314},{"date":"2021-08-20","current":-14.469939,"twenty":-14.417826,"median":-13.53723,"eighty":-12.946988,"marketCap":49788919},{"date":"2021-08-27","current":-15.554006,"twenty":-15.10781,"median":-14.271254,"eighty":-13.304373,"marketCap":53519033},{"date":"2021-09-03","current":-13.872917,"twenty":-15.546586,"median":-14.469939,"eighty":-13.425495,"marketCap":47734653},{"date":"2021-09-10","current":-11.987582,"twenty":-15.514027,"median":-14.20285,"eighty":-12.844352,"marketCap":41247497},{"date":"2021-09-17","current":-15.836806,"twenty":-15.554006,"median":-14.271254,"eighty":-12.616027,"marketCap":54492107},{"date":"2021-09-24","current":-13.857205,"twenty":-15.550296,"median":-13.938443,"eighty":-12.791992,"marketCap":47680593},{"date":"2021-10-01","current":-12.23896,"twenty":-15.514027,"median":-13.810072,"eighty":-12.616027,"marketCap":42112451},{"date":"2021-10-08","current":-12.066138,"twenty":-15.365473,"median":-13.700094,"eighty":-12.24897,"marketCap":41517795},{"date":"2021-10-15","current":-12.254672,"twenty":-15.066962,"median":-13.437221,"eighty":-12.094418,"marketCap":42166511},{"date":"2021-10-22","current":-11.264871,"twenty":-14.828152,"median":-13.254895,"eighty":-12.003293,"marketCap":38760754},{"date":"2021-10-29","current":-17.049854,"twenty":-15.514027,"median":-13.358664,"eighty":-12.003293,"marketCap":58666025},{"date":"2021-11-05","current":-17.930922,"twenty":-15.874513,"median":-13.53723,"eighty":-12.075565,"marketCap":61697649},{"date":"2021-11-12","current":-17.835672,"twenty":-16.960623,"median":-13.755083,"eighty":-12.132124,"marketCap":61369906},{"date":"2021-11-19","current":-8.792257,"twenty":-16.81718,"median":-13.53723,"eighty":-11.880747,"marketCap":46293721},{"date":"2021-11-26","current":-9.010118,"twenty":-16.528095,"median":-13.378591,"eighty":-11.484827,"marketCap":47440822},{"date":"2021-12-03","current":-8.10755,"twenty":-16.480962,"median":-13.241828,"eighty":-11.264871,"marketCap":42688546},{"date":"2021-12-10","current":-9.554771,"twenty":-15.88394,"median":-12.993094,"eighty":-10.504024,"marketCap":50308575},{"date":"2021-12-17","current":-9.368033,"twenty":-15.836806,"median":-12.529616,"eighty":-9.554771,"marketCap":49325345},{"date":"2021-12-23","current":-9.414717,"twenty":-15.610566,"median":-12.388216,"eighty":-9.40538,"marketCap":49571152},{"date":"2021-12-31","current":-8.870065,"twenty":-15.554006,"median":-12.289012,"eighty":-9.333798,"marketCap":46703400},{"date":"2022-01-07","current":-8.745572,"twenty":-15.539165,"median":-12.246816,"eighty":-9.284001,"marketCap":46047913},{"date":"2022-01-14","current":-8.216481,"twenty":-15.449745,"median":-12.113271,"eighty":-9.035016,"marketCap":43262097},{"date":"2022-01-21","current":-7.531774,"twenty":-15.239784,"median":-11.987582,"eighty":-8.870065,"marketCap":39656922},{"date":"2022-01-28","current":-7.142736,"twenty":-14.972695,"median":-11.854038,"eighty":-8.810931,"marketCap":37608527},{"date":"2022-02-04","current":-7.469528,"twenty":-14.727601,"median":-11.484827,"eighty":-8.717562,"marketCap":39329179},{"date":"2022-02-11","current":-7.562897,"twenty":-14.624015,"median":-11.296293,"eighty":-8.428118,"marketCap":39820793},{"date":"2022-02-18","current":-7.173859,"twenty":-14.596747,"median":-11.217738,"eighty":-8.344085,"marketCap":37772399},{"date":"2022-02-25","current":-6.504714,"twenty":-14.535926,"median":-11.10776,"eighty":-8.18847,"marketCap":34249160},{"date":"2022-03-04","current":-6.489152,"twenty":-14.417826,"median":-10.04496,"eighty":-7.967497,"marketCap":34167224},{"date":"2022-03-11","current":-5.804446,"twenty":-14.284934,"median":-9.601456,"eighty":-7.799432,"marketCap":30562049},{"date":"2022-03-18","current":-6.037868,"twenty":-14.097087,"median":-9.53921,"eighty":-7.709175,"marketCap":31791086},{"date":"2022-03-25","current":-4.508748,"twenty":-13.912233,"median":-9.461402,"eighty":-7.587795,"marketCap":34768693},{"date":"2022-04-01","current":-4.305265,"twenty":-13.866632,"median":-9.352472,"eighty":-7.385496,"marketCap":33199559},{"date":"2022-04-08","current":-3.962557,"twenty":-13.819499,"median":-9.321349,"eighty":-7.074265,"marketCap":30556808},{"date":"2022-04-14","current":-3.673398,"twenty":-13.759797,"median":-9.259103,"eighty":-6.707014,"marketCap":28326987},{"date":"2022-04-22","current":-3.512753,"twenty":-13.737801,"median":-9.13461,"eighty":-6.426906,"marketCap":27088198},{"date":"2022-04-29","current":-3.137917,"twenty":-13.667521,"median":-8.870065,"eighty":-6.000521,"marketCap":24197689},{"date":"2022-05-06","current":-3.127207,"twenty":-13.528954,"median":-8.862284,"eighty":-5.707964,"marketCap":24115103},{"date":"2022-05-13","current":-1.95729,"twenty":-13.472398,"median":-8.82338,"eighty":-4.98591,"marketCap":20481320},{"date":"2022-05-20","current":-2.170383,"twenty":-13.37062,"median":-8.745572,"eighty":-4.429497,"marketCap":22711141},{"date":"2022-05-27","current":-1.878367,"twenty":-13.321969,"median":-8.698888,"eighty":-4.28813,"marketCap":19655460},{"date":"2022-06-03","current":-1.941506,"twenty":-13.254895,"median":-8.449903,"eighty":-4.144621,"marketCap":20316148},{"date":"2022-06-10","current":-2.099352,"twenty":-13.228761,"median":-8.411,"eighty":-3.951848,"marketCap":21967868},{"date":"2022-06-17","current":-1.531106,"twenty":-13.228761,"median":-8.356534,"eighty":-3.646624,"marketCap":16021678},{"date":"2022-06-24","current":-1.602137,"twenty":-13.040227,"median":-8.216481,"eighty":-3.547024,"marketCap":16764951},{"date":"2022-07-01","current":-2.47029,"twenty":-12.791992,"median":-8.138673,"eighty":-3.422793,"marketCap":25849408},{"date":"2022-07-08","current":-2.509751,"twenty":-12.647449,"median":-8.0064,"eighty":-3.315696,"marketCap":26262338},{"date":"2022-07-15","current":-2.628136,"twenty":-12.518618,"median":-7.936373,"eighty":-3.122923,"marketCap":27501128},{"date":"2022-07-22","current":-2.359798,"twenty":-12.4652,"median":-7.8041,"eighty":-2.596931,"marketCap":24693205},{"date":"2022-07-29","current":-2.241413,"twenty":-12.374076,"median":-7.734074,"eighty":-2.486075,"marketCap":23454415},{"date":"2022-08-05","current":-2.628136,"twenty":-12.308089,"median":-7.702951,"eighty":-2.475025,"marketCap":27501128},{"date":"2022-08-12","current":-1.791421,"twenty":-12.294129,"median":-7.625143,"eighty":-2.440299,"marketCap":24693205},{"date":"2022-08-19","current":-1.47987,"twenty":-12.277835,"median":-7.508432,"eighty":-2.381896,"marketCap":20398734},{"date":"2022-08-26","current":-1.473878,"twenty":-12.260956,"median":-7.329474,"eighty":-2.321915,"marketCap":20316148},{"date":"2022-09-02","current":-1.455904,"twenty":-12.245245,"median":-7.127175,"eighty":-2.214579,"marketCap":20068390},{"date":"2022-09-09","current":-1.677585,"twenty":-12.226391,"median":-6.932656,"eighty":-2.146706,"marketCap":23124071},{"date":"2022-09-16","current":-1.647628,"twenty":-12.169831,"median":-6.707014,"eighty":-2.086724,"marketCap":22711141},{"date":"2022-09-23","current":-1.401982,"twenty":-12.094418,"median":-6.496933,"eighty":-1.988588,"marketCap":19325116},{"date":"2022-09-30","current":-1.294137,"twenty":-12.034716,"median":-6.349099,"eighty":-1.949398,"marketCap":17838569},{"date":"2022-10-07","current":-1.210258,"twenty":-11.975013,"median":-6.014526,"eighty":-1.900466,"marketCap":16682365},{"date":"2022-10-14","current":-1.078448,"twenty":-11.918454,"median":-5.804446,"eighty":-1.846798,"marketCap":14865474},{"date":"2022-10-21","current":-1.096422,"twenty":-11.85561,"median":-5.687735,"eighty":-1.791473,"marketCap":15113232},{"date":"2022-10-28","current":-1.081383,"twenty":-11.726778,"median":-5.073054,"eighty":-1.753669,"marketCap":14905941},{"date":"2022-11-04","current":-1.108464,"twenty":-11.522533,"median":-4.487329,"eighty":-1.712991,"marketCap":15279230},{"date":"2022-11-11","current":-1.13338,"twenty":-11.465973,"median":-4.423071,"eighty":-1.656016,"marketCap":15735104},{"date":"2022-11-18","current":-1.07675,"twenty":-11.381133,"median":-4.305265,"eighty":-1.620928,"marketCap":14948886},{"date":"2022-11-25","current":-1.053253,"twenty":-11.296293,"median":-4.267781,"eighty":-1.602847,"marketCap":14622671},{"date":"2022-12-02","current":-1.112382,"twenty":-11.290009,"median":-4.144621,"eighty":-1.575732,"marketCap":15443576},{"date":"2022-12-09","current":-1.011256,"twenty":-11.255444,"median":-4.042879,"eighty":-1.546973,"marketCap":14039614},{"date":"2022-12-16","current":-1.088587,"twenty":-11.211453,"median":-3.769784,"eighty":-1.499042,"marketCap":15113232},{"date":"2022-12-23","current":-0.919778,"twenty":-11.170604,"median":-3.658405,"eighty":-1.473878,"marketCap":12769591},{"date":"2022-12-30","current":-0.87742,"twenty":-11.10776,"median":-3.603785,"eighty":-1.431939,"marketCap":12181518},{"date":"2023-01-06","current":-0.956145,"twenty":-10.624771,"median":-3.534172,"eighty":-1.399585,"marketCap":13274494},{"date":"2023-01-13","current":-0.986341,"twenty":-10.279938,"median":-3.480625,"eighty":-1.310913,"marketCap":13693706},{"date":"2023-01-20","current":-0.992392,"twenty":-10.009168,"median":-3.405657,"eighty":-1.294137,"marketCap":13777717},{"date":"2023-01-27","current":-1.010545,"twenty":-9.847328,"median":-3.314626,"eighty":-1.203068,"marketCap":14029748},{"date":"2023-02-03","current":-1.028699,"twenty":-9.694825,"median":-3.137917,"eighty":-1.161384,"marketCap":14281779},{"date":"2023-02-10","current":-1.022648,"twenty":-9.573445,"median":-2.875532,"eighty":-1.133,"marketCap":14197769},{"date":"2023-02-17","current":-1.072993,"twenty":-9.545434,"median":-2.628136,"eighty":-1.114432,"marketCap":14896736},{"date":"2023-02-24","current":-1.01345,"twenty":-9.53921,"median":-2.588674,"eighty":-1.108428,"marketCap":14070073},{"date":"2023-03-03","current":-1.040801,"twenty":-9.532985,"median":-2.497913,"eighty":-1.09529,"marketCap":14449800},{"date":"2023-03-10","current":-1.022164,"twenty":-9.49875,"median":-2.486075,"eighty":-1.090502,"marketCap":14191048},{"date":"2023-03-17","current":-0.950212,"twenty":-9.442728,"median":-2.47029,"eighty":-1.08326,"marketCap":13609696},{"date":"2023-03-24","current":-1.114446,"twenty":-9.396043,"median":-2.446613,"eighty":-1.079622,"marketCap":15961989},{"date":"2023-03-31","current":-1.085119,"twenty":-9.355584,"median":-2.41899,"eighty":-1.074981,"marketCap":15541936},{"date":"2023-04-06","current":-1.040424,"twenty":-9.33691,"median":-2.379529,"eighty":-1.073479,"marketCap":14901777},{"date":"2023-04-14","current":-1.067522,"twenty":-9.333798,"median":-2.359798,"eighty":-1.072482,"marketCap":15289905},{"date":"2023-04-21","current":-1.643515,"twenty":-9.315124,"median":-2.269036,"eighty":-1.072667,"marketCap":23539733},{"date":"2023-04-28","current":-1.566384,"twenty":-9.284001,"median":-2.217736,"eighty":-1.073019,"marketCap":22434996},{"date":"2023-05-05","current":-1.46057,"twenty":-9.259103,"median":-2.158545,"eighty":-1.073174,"marketCap":20919447},{"date":"2023-05-12","current":-1.143774,"twenty":-9.252878,"median":-2.115136,"eighty":-1.073479,"marketCap":16382041},{"date":"2023-05-19","current":-1.15382,"twenty":-9.190631,"median":-2.087514,"eighty":-1.074411,"marketCap":17550627},{"date":"2023-05-26","current":-1.005195,"twenty":-9.035016,"median":-2.020429,"eighty":-1.074411,"marketCap":15289905},{"date":"2023-06-02","current":-0.961011,"twenty":-9.010118,"median":-1.983145,"eighty":-1.072993,"marketCap":14617821},{"date":"2023-06-09","current":-1.159841,"twenty":-8.870065,"median":-1.953344,"eighty":-1.072456,"marketCap":17642198},{"date":"2023-06-16","current":-1.082518,"twenty":-8.870065,"median":-1.941506,"eighty":-1.072586,"marketCap":16466052},{"date":"2023-06-23","current":-1.04938,"twenty":-8.870065,"median":-1.933614,"eighty":-1.070994,"marketCap":15961989},{"date":"2023-06-30","current":-0.972057,"twenty":-8.860728,"median":-1.878367,"eighty":-1.064921,"marketCap":14785842},{"date":"2023-07-07","current":-1.060426,"twenty":-8.848278,"median":-1.846798,"eighty":-1.061657,"marketCap":16130010},{"date":"2023-07-14","current":-1.071472,"twenty":-8.832717,"median":-1.814213,"eighty":-1.061657,"marketCap":16298031},{"date":"2023-07-21","current":-1.060426,"twenty":-8.810931,"median":-1.791421,"eighty":-1.060426,"marketCap":16130010},{"date":"2023-07-28","current":-1.04938,"twenty":-8.773583,"median":-1.779441,"eighty":-1.055258,"marketCap":15961989},{"date":"2023-08-04","current":-0.966534,"twenty":-8.745572,"median":-1.744198,"eighty":-1.055258,"marketCap":14701832},{"date":"2023-08-11","current":-1.220594,"twenty":-8.739348,"median":-1.725516,"eighty":-1.052876,"marketCap":18566313},{"date":"2023-08-18","current":-1.373317,"twenty":-8.717562,"median":-1.677585,"eighty":-1.053044,"marketCap":20078502},{"date":"2023-08-25","current":-1.465254,"twenty":-8.680214,"median":-1.662443,"eighty":-1.053913,"marketCap":21422669},{"date":"2023-09-01","current":-1.654875,"twenty":-8.571283,"median":-1.65362,"eighty":-1.055258,"marketCap":24195015},{"date":"2023-09-08","current":-1.815766,"twenty":-8.446791,"median":-1.659611,"eighty":-1.056424,"marketCap":26547308},{"date":"2023-09-15","current":-1.81002,"twenty":-8.43123,"median":-1.67756,"eighty":-1.0591,"marketCap":26463298},{"date":"2023-09-22","current":-1.91345,"twenty":-8.415669,"median":-1.712629,"eighty":-1.05983,"marketCap":27975486},{"date":"2023-09-29","current":-1.580176,"twenty":-8.396994,"median":-1.67756,"eighty":-1.060426,"marketCap":23102879},{"date":"2023-10-06","current":-1.505477,"twenty":-8.368984,"median":-1.659611,"eighty":-1.060672,"marketCap":22010743},{"date":"2023-10-13","current":-1.44227,"twenty":-8.350309,"median":-1.65362,"eighty":-1.061657,"marketCap":21086627},{"date":"2023-10-20","current":-1.5457,"twenty":-8.303625,"median":-1.643515,"eighty":-1.061657,"marketCap":22598816},{"date":"2023-10-27","current":-1.223918,"twenty":-8.260053,"median":-1.625814,"eighty":-1.061657,"marketCap":17894230},{"date":"2023-11-03","current":-1.430778,"twenty":-8.216481,"median":-1.607859,"eighty":-1.063416,"marketCap":20918607},{"date":"2023-11-10","current":-1.278395,"twenty":-8.18847,"median":-1.602137,"eighty":-1.064711,"marketCap":19273682},{"date":"2023-11-17","current":-1.198043,"twenty":-8.132448,"median":-1.590231,"eighty":-1.064921,"marketCap":18062251},{"date":"2023-11-24","current":-1.170181,"twenty":-8.082652,"median":-1.580176,"eighty":-1.066012,"marketCap":17642198},{"date":"2023-12-01","current":-1.259338,"twenty":-8.014181,"median":-1.575732,"eighty":-1.06881,"marketCap":18986366},{"date":"2023-12-08","current":-1.225904,"twenty":-7.967497,"median":-1.562071,"eighty":-1.070868,"marketCap":18482303},{"date":"2023-12-15","current":-1.097741,"twenty":-7.955047,"median":-1.551766,"eighty":-1.070868,"marketCap":16550062},{"date":"2023-12-22","current":-1.036335,"twenty":-7.917699,"median":-1.544264,"eighty":-1.066012,"marketCap":15624267},{"date":"2023-12-29","current":-0.975151,"twenty":-7.889689,"median":-1.542628,"eighty":-1.064589,"marketCap":14701832},{"date":"2024-01-05","current":-0.99744,"twenty":-7.852341,"median":-1.531031,"eighty":-1.061657,"marketCap":15037874},{"date":"2024-01-12","current":-1.003012,"twenty":-7.799432,"median":-1.530311,"eighty":-1.059391,"marketCap":15121884},{"date":"2024-01-19","current":-0.972365,"twenty":-7.774534,"median":-1.51201,"eighty":-1.056545,"marketCap":14659827},{"date":"2024-01-26","current":-0.957988,"twenty":-7.752748,"median":-1.506456,"eighty":-1.052876,"marketCap":14443080},{"date":"2024-02-02","current":-0.952806,"twenty":-7.727849,"median":-1.499731,"eighty":-1.04938,"marketCap":14364950},{"date":"2024-02-09","current":-0.947289,"twenty":-7.712288,"median":-1.498787,"eighty":-1.048264,"marketCap":14281779},{"date":"2024-02-16","current":-0.961945,"twenty":-7.702951,"median":-1.493985,"eighty":-1.041288,"marketCap":14502727},{"date":"2024-02-23","current":-1.064308,"twenty":-7.690502,"median":-1.483973,"eighty":-1.040499,"marketCap":16045999},{"date":"2024-03-01","current":-1.225904,"twenty":-7.637593,"median":-1.475312,"eighty":-1.040499,"marketCap":18482303},{"date":"2024-03-08","current":-1.053163,"twenty":-7.612694,"median":-1.473878,"eighty":-1.040801,"marketCap":15877978},{"date":"2024-03-15","current":-1.057432,"twenty":-7.556672,"median":-1.471,"eighty":-1.041044,"marketCap":16309266},{"date":"2024-03-22","current":-1.256738,"twenty":-7.522437,"median":-1.466001,"eighty":-1.041044,"marketCap":19383264},{"date":"2024-03-28","current":-1.378537,"twenty":-7.485089,"median":-1.465254,"eighty":-1.042018,"marketCap":21261818},{"date":"2024-04-05","current":-1.245666,"twenty":-7.469528,"median":-1.454833,"eighty":-1.043021,"marketCap":19212486},{"date":"2024-04-12","current":-1.52248,"twenty":-7.329474,"median":-1.448839,"eighty":-1.043856,"marketCap":23481928},{"date":"2024-04-19","current":-1.395145,"twenty":-7.173859,"median":-1.451415,"eighty":-1.047591,"marketCap":21517985},{"date":"2024-04-26","current":-1.206911,"twenty":-7.142736,"median":-1.448016,"eighty":-1.049273,"marketCap":18614764},{"date":"2024-05-03","current":-1.110026,"twenty":-7.111613,"median":-1.444968,"eighty":-1.04938,"marketCap":17120460},{"date":"2024-05-10","current":-1.188735,"twenty":-7.049367,"median":-1.436524,"eighty":-1.04938,"marketCap":17803571},{"date":"2024-05-17","current":-1.368328,"twenty":-6.815944,"median":-1.432009,"eighty":-1.04938,"marketCap":20493319},{"date":"2024-05-24","current":-1.345522,"twenty":-6.707014,"median":-1.430778,"eighty":-1.04938,"marketCap":20151763},{"date":"2024-05-31","current":-1.413938,"twenty":-6.707014,"median":-1.427905,"eighty":-1.04938,"marketCap":21176429},{"date":"2024-06-07","current":-1.500542,"twenty":-6.545174,"median":-1.430778,"eighty":-1.04938,"marketCap":22473486},{"date":"2024-06-14","current":-1.391133,"twenty":-6.504714,"median":-1.429342,"eighty":-1.051467,"marketCap":20834874},{"date":"2024-06-21","current":-1.322717,"twenty":-6.498489,"median":-1.426468,"eighty":-1.052876,"marketCap":19810208},{"date":"2024-06-28","current":-1.299911,"twenty":-6.492264,"median":-1.422336,"eighty":-1.052895,"marketCap":19468653},{"date":"2024-07-05","current":-1.191585,"twenty":-6.442468,"median":-1.413952,"eighty":-1.053059,"marketCap":17846265},{"date":"2024-07-12","current":-1.265703,"twenty":-6.373997,"median":-1.413587,"eighty":-1.053217,"marketCap":18956320},{"date":"2024-07-15","current":-1.282807,"twenty":-6.361548,"median":-1.410912,"eighty":-1.053235,"marketCap":19212486},{"date":"2024-08-02","current":-1.16878,"twenty":-6.349099,"median":-1.408237,"eighty":-1.053253,"marketCap":17504710},{"date":"2024-08-09","current":-0.986393,"twenty":-6.271291,"median":-1.402259,"eighty":-1.052858,"marketCap":14773121},{"date":"2024-08-16","current":-1.081392,"twenty":-6.037868,"median":-1.396301,"eighty":-1.052904,"marketCap":17028796},{"date":"2024-08-23","current":-1.029588,"twenty":-5.991184,"median":-1.393111,"eighty":-1.04938,"marketCap":16213045},{"date":"2024-08-30","current":-1.074916,"twenty":-5.991184,"median":-1.389999,"eighty":-1.04938,"marketCap":16926827},{"date":"2024-09-06","current":-0.977785,"twenty":-5.841794,"median":-1.384008,"eighty":-1.04938,"marketCap":15397294},{"date":"2024-09-13","current":-0.990736,"twenty":-5.767098,"median":-1.379134,"eighty":-1.04873,"marketCap":15601232},{"date":"2024-09-20","current":-0.97131,"twenty":-5.707964,"median":-1.373317,"eighty":-1.041775,"marketCap":15295326},{"date":"2024-09-27","current":-0.686392,"twenty":-5.683066,"median":-1.365128,"eighty":-1.038333,"marketCap":10808697},{"date":"2024-10-04","current":-0.757622,"twenty":-5.393622,"median":-1.350855,"eighty":-1.035908,"marketCap":11930354},{"date":"2024-10-11","current":-0.73172,"twenty":-5.122851,"median":-1.344222,"eighty":-1.03475,"marketCap":11522478},{"date":"2024-10-18","current":-1.003687,"twenty":-4.98591,"median":-1.334119,"eighty":-1.032714,"marketCap":15805170},{"date":"2024-10-25","current":-0.964835,"twenty":-4.599823,"median":-1.327905,"eighty":-1.030617,"marketCap":15193357},{"date":"2024-10-31","current":-0.80295,"twenty":-4.483045,"median":-1.31871,"eighty":-1.028976,"marketCap":12644136},{"date":"2024-11-08","current":-0.770572,"twenty":-4.459483,"median":-1.312111,"eighty":-1.028699,"marketCap":12134291},{"date":"2024-11-15","current":-0.770221,"twenty":-4.435922,"median":-1.306342,"eighty":-1.022927,"marketCap":11471494},{"date":"2024-11-22","current":-0.71545,"twenty":-4.416645,"median":-1.301028,"eighty":-1.021764,"marketCap":10655743},{"date":"2024-11-29","current":-0.698334,"twenty":-4.369523,"median":-1.298344,"eighty":-1.019729,"marketCap":10400821},{"date":"2024-12-06","current":-0.657256,"twenty":-4.305265,"median":-1.294174,"eighty":-1.016645,"marketCap":9789008},{"date":"2024-12-13","current":-0.691488,"twenty":-4.296697,"median":-1.294137,"eighty":-1.016551,"marketCap":10298852},{"date":"2024-12-20","current":-0.609331,"twenty":-4.270994,"median":-1.28442,"eighty":-1.013136,"marketCap":9075226},{"date":"2024-12-27","current":-0.581945,"twenty":-4.247433,"median":-1.280601,"eighty":-1.010687,"marketCap":8667351},{"date":"2025-01-03","current":-0.585231,"twenty":-4.230298,"median":-1.272375,"eighty":-1.006355,"marketCap":8716296},{"date":"2025-01-10","current":-0.664102,"twenty":-4.161756,"median":-1.268003,"eighty":-1.003552,"marketCap":9890977},{"date":"2025-01-17","current":-0.575167,"twenty":-4.136053,"median":-1.261084,"eighty":-0.998976,"marketCap":8566402},{"date":"2025-01-24","current":-0.88189,"twenty":-4.127485,"median":-1.260002,"eighty":-0.99744,"marketCap":13134654},{"date":"2025-01-31","current":-0.886631,"twenty":-4.026815,"median":-1.257464,"eighty":-0.993446,"marketCap":13205270},{"date":"2025-02-07","current":-0.760417,"twenty":-3.956132,"median":-1.245666,"eighty":-0.988608,"marketCap":11325461},{"date":"2025-02-14","current":-0.742399,"twenty":-3.84261,"median":-1.238589,"eighty":-0.98707,"marketCap":11057119},{"date":"2025-02-21","current":-0.730167,"twenty":-3.73123,"median":-1.231675,"eighty":-0.985779,"marketCap":10874928},{"date":"2025-02-28","current":-0.745082,"twenty":-3.672113,"median":-1.225904,"eighty":-0.981039,"marketCap":11097073},{"date":"2025-03-07","current":-0.768098,"twenty":-3.660761,"median":-1.225849,"eighty":-0.980463,"marketCap":11439860},{"date":"2025-03-14","current":-0.75853,"twenty":-3.63163,"median":-1.220594,"eighty":-0.977669,"marketCap":11394665},{"date":"2025-03-21","current":-0.725399,"twenty":-3.604856,"median":-1.214046,"eighty":-0.975565,"marketCap":10896965},{"date":"2025-03-28","current":-0.62435,"twenty":-3.581295,"median":-1.208689,"eighty":-0.974516,"marketCap":9379008},{"date":"2025-04-04","current":-0.451645,"twenty":-3.538456,"median":-1.2078,"eighty":-0.972057,"marketCap":6784630},{"date":"2025-04-11","current":-0.461059,"twenty":-3.504185,"median":-1.201375,"eighty":-0.9697,"marketCap":6926037},{"date":"2025-04-17","current":-0.46394,"twenty":-3.489192,"median":-1.198043,"eighty":-0.966865,"marketCap":6969324},{"date":"2025-04-25","current":-0.476427,"twenty":-3.469915,"median":-1.196616,"eighty":-0.961198,"marketCap":7156905},{"date":"2025-05-02","current":-0.451453,"twenty":-3.422793,"median":-1.191585,"eighty":-0.952817,"marketCap":6781744},{"date":"2025-05-09","current":-0.409531,"twenty":-3.388522,"median":-1.187817,"eighty":-0.95007,"marketCap":6151980},{"date":"2025-05-16","current":-0.384834,"twenty":-3.31998,"median":-1.181326,"eighty":-0.947289,"marketCap":6060282},{"date":"2025-05-23","current":-0.386306,"twenty":-3.317838,"median":-1.173755,"eighty":-0.94295,"marketCap":6083468},{"date":"2025-05-30","current":-0.407281,"twenty":-3.309271,"median":-1.171024,"eighty":-0.938933,"marketCap":6413777},{"date":"2025-06-06","current":-0.353215,"twenty":-3.234303,"median":-1.170014,"eighty":-0.93188,"marketCap":5562348},{"date":"2025-06-12","current":-0.351178,"twenty":-3.157194,"median":-1.168157,"eighty":-0.927577,"marketCap":5530279}],"updateTime":1749810175512}}}